Vivalyx Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$2.6M
- Investors
-
20
Vivalyx General Information
Description
Operator of a patented organ preservation company intended to improve the success of organ transplantation. The company offers a cell-free and oxygen carrier-free perfusate for normothermic machine perfusion and cold storage, enabling medical professionals to reduce biliary complications and improve renal function in transplanted organs without the need for blood-based resources.
Contact Information
Website
www.vivalyx.comCorporate Office
- Gottfried-Hagen-Straße 60-62
- 51105 Cologne
- Germany
Corporate Office
- Gottfried-Hagen-Straße 60-62
- 51105 Cologne
- Germany
Vivalyx Timeline
Vivalyx Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Grant | 19-Feb-2025 | $2.6M | Completed | Generating Revenue | ||
| 7. Early Stage VC | 01-Jan-2025 | Completed | Generating Revenue | |||
| 6. Seed Round | 30-Apr-2024 | Completed | Generating Revenue | |||
| 5. Seed Round | 15-Jun-2023 | Completed | Pre-Clinical Trials | |||
| 4. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 1. Accelerator/Incubator | Completed | Pre-Clinical Trials |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Vivalyx Patents
Vivalyx Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026073910-A1 | Device for transporting an organ or tissue | Pending | 02-Oct-2024 | ||
| WO-2026073913-A1 | Device for transporting an organ or tissue | Pending | 02-Oct-2024 | ||
| CA-2981588-A1 | Organ preservation composition | Active | 03-Apr-2015 | ||
| EP-3277083-A1 | Organ preservation composition | Active | 03-Apr-2015 | ||
| US-10874098-B2 | Organ preservation composition | Active | 03-Apr-2015 | A01N1/126 |
Vivalyx Signals
Vivalyx Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| European Innovation Council | Accelerator/Incubator | Minority | ||
| Deepbright Ventures | Venture Capital | Minority | ||
| Nextgen Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Angel Invest | Venture Capital | Minority |
Vivalyx FAQs
-
When was Vivalyx founded?
Vivalyx was founded in 2022.
-
Where is Vivalyx headquartered?
Vivalyx is headquartered in Cologne, Germany.
-
What is the size of Vivalyx?
Vivalyx has 9 total employees.
-
What industry is Vivalyx in?
Vivalyx’s primary industry is Medical Supplies.
-
Is Vivalyx a private or public company?
Vivalyx is a Private company.
-
What is Vivalyx’s current revenue?
The current revenue for Vivalyx is .
-
How much funding has Vivalyx raised over time?
Vivalyx has raised $5.79M.
-
Who are Vivalyx’s investors?
European Innovation Council, Deepbright Ventures, Nextgen Ventures, , and Angel Invest are 5 of 20 investors who have invested in Vivalyx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process